| Nombre del producto |
Adriamycin |
| Nombre en inglés |
Adriamycin; 10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 14-Hydroxydaunomycin; (8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione; adiblastine (hydrochloride salt); adriablastine (hydrochloride salt); adriablatina (hydrochloride salt); Adriacin; Adriacin (hydrochloride salt); Adriamycin PFS; Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (hydrochloride salt); Adriblastin; Adriblastina; Adriblastina (hydrochloride salt); adriblatina (hydrochloride salt); Doxorubicin; Doxorubicin hydrochloride (hydrochloride salt); Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); Rubex; Rubex (hydrochloride salt); (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
| Fórmula molecular |
C27H29NO11 |
| Peso Molecular |
543.5193 |
| InChI |
InChI=1/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 |
| Número de registro CAS |
23214-92-8 |
| EINECS |
245-495-6 |
| Estructura Molecular |
|
| Densidad |
1.61g/cm3 |
| Punto de fusión |
205℃ |
| Punto de ebullición |
810.3°C at 760 mmHg |
| Índice de refracción |
1.709 |
| Punto de inflamación |
443.8°C |
| Solubilidad en agua |
Soluble |
| Presión de vapor |
9.64E-28mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
